JX LUXVENTURE GROUP INC (JXG) Fundamental Analysis & Valuation

NASDAQ:JXG • MHY460024018

Current stock price

3.77 USD
+0.04 (+1.07%)
Last:

This JXG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. JXG Profitability Analysis

1.1 Basic Checks

  • In the past year JXG was profitable.
  • In the past year JXG has reported a negative cash flow from operations.
  • In multiple years JXG reported negative net income over the last 5 years.
  • In the past 5 years JXG reported 4 times negative operating cash flow.
JXG Yearly Net Income VS EBIT VS OCF VS FCFJXG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • JXG's Return On Assets of 15.20% is amongst the best of the industry. JXG outperforms 95.56% of its industry peers.
  • JXG's Return On Equity of 20.00% is amongst the best of the industry. JXG outperforms 82.22% of its industry peers.
  • The Return On Invested Capital of JXG (16.25%) is better than 84.44% of its industry peers.
Industry RankSector Rank
ROA 15.2%
ROE 20%
ROIC 16.25%
ROA(3y)-142.21%
ROA(5y)-106.68%
ROE(3y)-187.56%
ROE(5y)-138.71%
ROIC(3y)N/A
ROIC(5y)N/A
JXG Yearly ROA, ROE, ROICJXG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

  • JXG has a Profit Margin of 6.39%. This is in the better half of the industry: JXG outperforms 77.78% of its industry peers.
  • With a decent Operating Margin value of 7.42%, JXG is doing good in the industry, outperforming 64.44% of the companies in the same industry.
  • JXG's Operating Margin has improved in the last couple of years.
  • JXG has a worse Gross Margin (17.10%) than 88.89% of its industry peers.
  • In the last couple of years the Gross Margin of JXG has declined.
Industry RankSector Rank
OM 7.42%
PM (TTM) 6.39%
GM 17.1%
OM growth 3YN/A
OM growth 5Y25.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y120.04%
GM growth 5Y-13.65%
JXG Yearly Profit, Operating, Gross MarginsJXG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. JXG Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), JXG is creating some value.
  • The number of shares outstanding for JXG has been increased compared to 1 year ago.
  • JXG has more shares outstanding than it did 5 years ago.
  • JXG has a worse debt/assets ratio than last year.
JXG Yearly Shares OutstandingJXG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50K 100K
JXG Yearly Total Debt VS Total AssetsJXG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of 1.54, we must say that JXG is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of JXG (1.54) is worse than 84.44% of its industry peers.
  • A Debt/Equity ratio of 0.15 indicates that JXG is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.15, JXG is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 1.54
ROIC/WACC1.8
WACC9.03%
JXG Yearly LT Debt VS Equity VS FCFJXG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 2.09 indicates that JXG has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.09, JXG is in line with its industry, outperforming 53.33% of the companies in the same industry.
  • JXG has a Quick Ratio of 2.09. This indicates that JXG is financially healthy and has no problem in meeting its short term obligations.
  • JXG's Quick ratio of 2.09 is amongst the best of the industry. JXG outperforms 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 2.09
JXG Yearly Current Assets VS Current LiabilitesJXG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. JXG Growth Analysis

3.1 Past

  • JXG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.69%.
  • JXG shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.98%.
  • The Revenue has been growing by 24.79% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-38.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.72%
Revenue 1Y (TTM)24.98%
Revenue growth 3Y-2.66%
Revenue growth 5Y24.79%
Sales Q2Q%-10.66%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JXG Yearly Revenue VS EstimatesJXG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

Find the best growth stocksShow best growing peers

3

4. JXG Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 0.21, the valuation of JXG can be described as very cheap.
  • JXG's Price/Earnings ratio is rather cheap when compared to the industry. JXG is cheaper than 100.00% of the companies in the same industry.
  • JXG's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.21.
Industry RankSector Rank
PE 0.21
Fwd PE N/A
JXG Price Earnings VS Forward Price EarningsJXG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, JXG is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.2
JXG Per share dataJXG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. JXG Dividend Analysis

5.1 Amount

  • JXG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

JXG Fundamentals: All Metrics, Ratios and Statistics

JX LUXVENTURE GROUP INC

NASDAQ:JXG (4/6/2026, 8:00:03 PM)

3.77

+0.04 (+1.07%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.32%
Inst Owner ChangeN/A
Ins Owners26.59%
Ins Owner Change55.07%
Market Cap17.04M
Revenue(TTM)75.02M
Net Income(TTM)4.79M
AnalystsN/A
Price TargetN/A
Short Float %0.25%
Short Ratio1.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.21
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 0.71
P/tB 1.68
EV/EBITDA 2.2
EPS(TTM)17.91
EY475.07%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-1.02
OCFYN/A
SpS16.6
BVpS5.3
TBVpS2.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number46.22
Profitability
Industry RankSector Rank
ROA 15.2%
ROE 20%
ROCE 23.24%
ROIC 16.25%
ROICexc 16.39%
ROICexgc 33.05%
OM 7.42%
PM (TTM) 6.39%
GM 17.1%
FCFM N/A
ROA(3y)-142.21%
ROA(5y)-106.68%
ROE(3y)-187.56%
ROE(5y)-138.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y127.4%
ROICexc growth 3YN/A
ROICexc growth 5Y73.53%
OM growth 3YN/A
OM growth 5Y25.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y120.04%
GM growth 5Y-13.65%
F-Score4
Asset Turnover2.38
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA 0.47
Cap/Depr 16.45%
Cap/Sales 0.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.09
Quick Ratio 2.09
Altman-Z 1.54
F-Score4
WACC9.03%
ROIC/WACC1.8
Cap/Depr(3y)1417.49%
Cap/Depr(5y)938.38%
Cap/Sales(3y)8.19%
Cap/Sales(5y)6.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.98%
Revenue growth 3Y-2.66%
Revenue growth 5Y24.79%
Sales Q2Q%-10.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.35%
EBIT growth 3YN/A
EBIT growth 5Y57.22%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.75%
OCF growth 3YN/A
OCF growth 5YN/A

JX LUXVENTURE GROUP INC / JXG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for JX LUXVENTURE GROUP INC?

ChartMill assigns a fundamental rating of 3 / 10 to JXG.


What is the valuation status for JXG stock?

ChartMill assigns a valuation rating of 3 / 10 to JX LUXVENTURE GROUP INC (JXG). This can be considered as Overvalued.


What is the profitability of JXG stock?

JX LUXVENTURE GROUP INC (JXG) has a profitability rating of 4 / 10.


How financially healthy is JX LUXVENTURE GROUP INC?

The financial health rating of JX LUXVENTURE GROUP INC (JXG) is 4 / 10.